From the perspective of signaling pathways, mainstream research indicates that glutamine addiction is associated with the progression and metastasis of prostate cancer cells through three distinct pathways: the AR pathway, the MYC pathway, and the PTEN/PI3K/mTOR pathway. Here, MTOR is linked to prostate carcinoma.